Bowel movement frequency in late-life and substantia nigra neuron density at death
- PMID: 19006191
- PMCID: PMC3272050
- DOI: 10.1002/mds.22360
Bowel movement frequency in late-life and substantia nigra neuron density at death
Abstract
Constipation is associated with future risk of Parkinson's disease (PD) and with incidental Lewy bodies (LB) in the locus ceruleus or substantia nigra (SN). Our purpose is to examine the independent association between bowel movement frequency in late-life and postmortem SN neuron density. Bowel movement frequency was assessed in the Honolulu-Asia Aging Study from 1991 to 1993 in 414 men aged 71 to 93 years with later postmortem evaluations. Brains were examined for LB in the SN and locus ceruleus and neurons were counted in four quadrants from a transverse section of SN. In nonsmokers, neuron densities (counts/mm(2)) for men with >1, 1, and <1 bowel movement daily were 18.5, 18.8, 10.1 (P < 0.001) for dorsomedial; 15.3, 16.4, 10.2 (P < 0.03) for ventromedial; and 18.6, 18.3, 10.9 (P = 0.011) for ventrolateral quadrants. Relationships were not significant in the dorsolateral quadrant or in any quadrant among smokers. After adjustment for age, time to death, coffee drinking, tricep skinfold thickness, excessive daytime sleepiness, cognitive function, PD, and incidental LB, density ratios in nonsmokers with 1 or more bowel movement(s) daily were significantly higher compared to those with <1 daily. Constipation is associated with low SN neuron density independent of the presence of LB.
(c) 2008 Movement Disorder Society.
Similar articles
-
Bowel movement frequency in late-life and incidental Lewy bodies.Mov Disord. 2007 Aug 15;22(11):1581-6. doi: 10.1002/mds.21560. Mov Disord. 2007. PMID: 17523195
-
[Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].No To Shinkei. 1993 Nov;45(11):1033-8. No To Shinkei. 1993. PMID: 8135950 Japanese.
-
Marinesco bodies and substantia nigra neuron density in Parkinson's disease.Neuropathol Appl Neurobiol. 2017 Dec;43(7):621-630. doi: 10.1111/nan.12419. Epub 2017 Jul 9. Neuropathol Appl Neurobiol. 2017. PMID: 28626918 Free PMC article.
-
[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. doi: 10.5692/clinicalneurol.48.981. Rinsho Shinkeigaku. 2008. PMID: 19198138 Review. Japanese.
-
Centenary of Lewy bodies (1912-2012).J Neural Transm (Vienna). 2013 Apr;120(4):509-16. doi: 10.1007/s00702-013-0984-2. Epub 2013 Mar 2. J Neural Transm (Vienna). 2013. PMID: 23456291 Review.
Cited by
-
Non-motor and motor features in LRRK2 transgenic mice.PLoS One. 2013 Jul 30;8(7):e70249. doi: 10.1371/journal.pone.0070249. Print 2013. PLoS One. 2013. PMID: 23936174 Free PMC article.
-
Gastrointestinal features of Parkinson's disease.Curr Neurol Neurosci Rep. 2011 Aug;11(4):379-84. doi: 10.1007/s11910-011-0204-0. Curr Neurol Neurosci Rep. 2011. PMID: 21499704 Review.
-
Midlife milk consumption and substantia nigra neuron density at death.Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658906 Free PMC article.
-
The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment.Curr Alzheimer Res. 2012 Jul;9(6):664-72. doi: 10.2174/156720512801322618. Curr Alzheimer Res. 2012. PMID: 22471866 Free PMC article.
-
Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.J Alzheimers Dis Parkinsonism. 2016 Nov;6(6):279. doi: 10.4172/2161-0460.1000279. Epub 2016 Nov 3. J Alzheimers Dis Parkinsonism. 2016. PMID: 28090391 Free PMC article.
References
-
- Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology. 2001;57:456–462. - PubMed
-
- Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM. Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord. 1997;12:946–951. - PubMed
-
- Astarloa R, Mena MA, Sanchez V, de l V, de Yebenes JG. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin Neuropharmacol. 1992;15:375–380. - PubMed
-
- Byrne KG, Pfeiffer R, Quigley EM. Gastrointestinal dysfunction in Parkinson's disease. A report of clinical experience at a single center. J Clin Gastroenterol. 1994;19:11–16. - PubMed
-
- Edwards L, Quigley EM, Hofman R, Pfeiffer RF. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord. 1993;8:83–86. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical